KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Invested Capital (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Invested Capital for 11 consecutive years, with $293.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 66.69% year-over-year to $293.6 million, compared with a TTM value of $293.6 million through Sep 2025, down 66.69%, and an annual FY2024 reading of $825.5 million, up 47.7% over the prior year.
  • Invested Capital was $293.6 million for Q3 2025 at Medpace Holdings, up from $172.4 million in the prior quarter.
  • Across five years, Invested Capital topped out at $952.9 million in Q4 2021 and bottomed at $172.4 million in Q2 2025.
  • Average Invested Capital over 5 years is $619.2 million, with a median of $593.6 million recorded in 2025.
  • The sharpest move saw Invested Capital soared 87.18% in 2024, then tumbled 77.43% in 2025.
  • Year by year, Invested Capital stood at $952.9 million in 2021, then tumbled by 54.21% to $436.4 million in 2022, then grew by 28.09% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then crashed by 64.43% to $293.6 million in 2025.
  • Business Quant data shows Invested Capital for MEDP at $293.6 million in Q3 2025, $172.4 million in Q2 2025, and $593.6 million in Q1 2025.